
Cidara Therapeutics CDTX
Country |
|
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
6.35 M |
Market Cap[1] |
$ 1.41 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Deciphera Pharmaceuticals
DCPH
|
- | - | $ 2.18 B | Nasdaq Global Select Market,SPB | ||
|
Entasis Therapeutics Holdings
ETTX
|
- | - | $ 105 M | Nasdaq Global Market | ||
|
Global Blood Therapeutics
GBT
|
- | - | $ 4.62 B | Nasdaq Global Select Market,SPB | ||
|
Idera Pharmaceuticals
IDRA
|
- | -23.04 % | $ 26.6 M | Nasdaq Global Select Market | ||
|
ImmunoGen
IMGN
|
- | - | $ 7.92 B | Nasdaq Global Select Market | ||
|
Infinity Pharmaceuticals
INFI
|
- | -46.98 % | $ 3.57 M | Nasdaq Global Select Market | ||
|
Novan
NOVN
|
- | -24.84 % | $ 2.64 M | Nasdaq Capital Market | ||
|
NanoString Technologies
NSTG
|
- | -37.43 % | $ 5.1 M | Nasdaq Global Select Market | ||
|
Orgenesis
ORGS
|
- | -33.86 % | $ 61.2 M | Nasdaq Capital Market | ||
|
Gossamer Bio
GOSS
|
$ 8.9 | 5.17 % | $ 2.03 B | Nasdaq Global Select Market,SPB | ||
|
GeoVax Labs
GOVX
|
$ 0.24 | 0.34 % | $ 230 K | Nasdaq Global Select Market | ||
|
Genprex
GNPX
|
$ 2.33 | 0.48 % | $ 2.17 M | Nasdaq Capital Market | ||
|
GT Biopharma
GTBP
|
$ 6.21 | 5.44 % | $ 34.2 M | Nasdaq Capital Market | ||
|
Agenus
AGEN
|
$ 6.5 | 1.29 % | $ 193 M | Nasdaq Capital Market | ||
|
Halozyme Therapeutics
HALO
|
$ 116.82 | 6.57 % | $ 14 B | Nasdaq Global Select Market,SPB | ||
|
Hutchison China MediTech Limited
HCM
|
$ 13.48 | 0.15 % | $ 11.6 B | Nasdaq Global Select Market | ||
|
Alector
ALEC
|
$ 1.88 | 0.53 % | $ 194 M | Nasdaq Global Select Market,SPB | ||
|
Harmony Biosciences Holdings
HRMY
|
$ 37.51 | 1.3 % | $ 2.16 B | Nasdaq Global Select Market | ||
|
Heron Therapeutics
HRTX
|
$ 0.36 | 0.31 % | $ 60 M | Nasdaq Global Select Market,SPB | ||
|
Arvinas
ARVN
|
$ 6.82 | 0.15 % | $ 484 M | Nasdaq Global Select Market,SPB | ||
|
Immunome
IMNM
|
$ 17.2 | 0.8 % | $ 1.5 B | Nasdaq Global Select Market | ||
|
Autolus Therapeutics plc
AUTL
|
$ 1.69 | 4.32 % | $ 450 M | Nasdaq Global Select Market | ||
|
INmune Bio
INMB
|
$ 1.6 | 2.38 % | $ 39.6 M | Nasdaq Capital Market | ||
|
Axon Enterprise
AXON
|
$ 408.42 | 0.42 % | $ 31.9 B | Nasdaq Global Select Market,SPB | ||
|
Innoviva
INVA
|
$ 20.97 | 1.11 % | $ 1.41 B | Nasdaq Global Select Market | ||
|
Ionis Pharmaceuticals
IONS
|
$ 42.7 | 0.76 % | $ 6.83 B | Nasdaq Global Select Market,SPB | ||
|
iBio
IBIO
|
$ 0.78 | 0.08 % | $ 81.2 M | NYSE American | ||
|
Innate Pharma S.A.
IPHA
|
$ 1.43 | 9.46 % | $ 128 M | Nasdaq Global Select Market | ||
|
BridgeBio Pharma
BBIO
|
$ 64.94 | 2.59 % | $ 12.4 B | Nasdaq Global Select Market,SPB | ||
|
Inventiva S.A.
IVA
|
$ 2.87 | 0.7 % | $ 172 M | Nasdaq Global Market | ||
|
Johnson & Johnson
JNJ
|
$ 253.91 | 2.13 % | $ 611 B | NYSE,SPB | ||
|
InMed Pharmaceuticals
INM
|
$ 1.31 | 0.75 % | $ 5.45 M | Nasdaq Capital Market | ||
|
Inovio Pharmaceuticals
INO
|
$ 0.99 | 0.68 % | $ 46.4 M | Nasdaq Global Select Market | ||
|
Insmed Incorporated
INSM
|
$ 97.79 | 1.03 % | $ 19.5 B | Nasdaq Global Select Market | ||
|
Kodiak Sciences
KOD
|
$ 81.09 | 0.13 % | $ 4.31 B | Nasdaq Global Market,SPB | ||
|
Keros Therapeutics
KROS
|
$ 11.05 | 0.45 % | $ 411 M | Nasdaq Global Select Market | ||
|
Ironwood Pharmaceuticals
IRWD
|
$ 3.6 | 0.28 % | $ 583 M | Nasdaq Global Select Market | ||
|
Kura Oncology
KURA
|
$ 9.61 | 0.19 % | $ 843 M | Nasdaq Global Select Market | ||
|
Lineage Cell Therapeutics
LCTX
|
$ 0.92 | 1.01 % | $ 212 M | NYSE American | ||
|
Immuron Limited
IMRN
|
$ 1.03 | 1.92 % | $ 238 M | Nasdaq Global Select Market | ||
|
Legend Biotech Corporation
LEGN
|
$ 19.04 | 6.49 % | $ 7.02 B | Nasdaq Global Select Market | ||
|
Longeveron
LGVN
|
$ 1.73 | 0.81 % | $ 30.4 B | Nasdaq Global Select Market | ||
|
Eli Lilly and Company
LLY
|
$ 1 208.74 | 3.62 % | $ 1.08 T | NYSE,SPB | ||
|
Kazia Therapeutics Limited
KZIA
|
$ 6.79 | 0.5 % | $ 104 M | Nasdaq Global Select Market | ||
|
Lipocine
LPCN
|
$ 1.69 | 4.32 % | $ 9.21 M | Nasdaq Global Select Market | ||
|
Liquidia Corporation
LQDA
|
$ 33.94 | 26.59 % | $ 2.92 B | Nasdaq Capital Market | ||
|
CNS Pharmaceuticals
CNSP
|
$ 5.35 | 3.08 % | $ 2.37 M | Nasdaq Capital Market | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | ||
|
Lexicon Pharmaceuticals
LXRX
|
$ 1.6 | 0.31 % | $ 581 M | Nasdaq Global Select Market | ||
|
Moleculin Biotech
MBRX
|
$ 0.41 | 5.15 % | $ 486 K | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.